These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes. Doria A; Yang Y; Malecki M; Scotti S; Dreyfus J; O'Keeffe C; Orban T; Warram JH; Krolewski AS Diabetes Care; 1999 Feb; 22(2):253-61. PubMed ID: 10333942 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus. Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037 [TBL] [Abstract][Full Text] [Related]
7. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests. Deng Y; Zhang Y; Zheng S; Hong J; Wang C; Liu T; Sun Z; Gu W; Gu Y; Shi J; Yao S; Wang W; Ning G J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350 [TBL] [Abstract][Full Text] [Related]
8. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM. Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B Diabetologia; 1996 Dec; 39(12):1546-53. PubMed ID: 8960841 [TBL] [Abstract][Full Text] [Related]
10. Diabetogenic effects of somatostatin in maturity-onset diabetes and normal man: primacy of insulin deficiency rather than glucagon excess in the pathogenesis of diabetes. Sherwin RS; Tamborlane WV; Hendler R; Felig P Metabolism; 1978 Sep; 27(9 Suppl 1):1433-6. PubMed ID: 683012 [No Abstract] [Full Text] [Related]
11. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in maturity onset diabetes of the young. Mohan V; Sharp PS; Aber VR; Mather HM; Kohner EM Diabete Metab; 1987 Jun; 13(3):193-7. PubMed ID: 3301443 [TBL] [Abstract][Full Text] [Related]
13. Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects. Shah M; Franklin B; Adams-Huet B; Mitchell J; Bouza B; Dart L; Phillips M Eur J Nutr; 2017 Apr; 56(3):1053-1062. PubMed ID: 26759261 [TBL] [Abstract][Full Text] [Related]
14. C-Peptide responses to glucose load in maturity-onset diabetes of the young (MODY). Mohan V; Snehalatha C; Ramachandran A; Jayashree R; Viswanathan M Diabetes Care; 1985; 8(1):69-72. PubMed ID: 3882370 [TBL] [Abstract][Full Text] [Related]
15. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855 [TBL] [Abstract][Full Text] [Related]
16. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). Carlsson A; Sundkvist G; Groop L; Tuomi T J Clin Endocrinol Metab; 2000 Jan; 85(1):76-80. PubMed ID: 10634367 [TBL] [Abstract][Full Text] [Related]
17. Abnormalities in insulin secretion in healthy offspring of Indian patients with maturity-onset diabetes of the young. Mohan V; Snehalatha C; Ramachandran A; Viswanathan M Diabetes Care; 1986; 9(1):53-6. PubMed ID: 3512208 [TBL] [Abstract][Full Text] [Related]
18. Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes. Kozawa J; Okita K; Iwahashi H; Yamagata K; Imagawa A; Shimomura I Endocr J; 2013; 60(6):813-8. PubMed ID: 23459463 [TBL] [Abstract][Full Text] [Related]
19. Dynamic changes in insulin and glucagon during disease progression in rhesus monkeys with obesity-related type 2 diabetes mellitus. Wang C; Xiao Y; Wang J; Hou N; Cui W; Hu X; Zeng F; Yuan Y; Ma D; Sun X; Zhang Y; Zheng W; Liu Y; Shang H; Chen L; Xiao RP; Zhang X Diabetes Obes Metab; 2019 May; 21(5):1111-1120. PubMed ID: 30575251 [TBL] [Abstract][Full Text] [Related]
20. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement. Scheen AJ; Castillo MJ; Lefèbvre PJ Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655 [No Abstract] [Full Text] [Related] [Next] [New Search]